🎯Focal therapy for #prostatecancer is a new option in the armamentarium. Technological improvements and the development of novel energy sources should make it possible to treat lesions with even greater precision, while limiting the risk of side effects. https://t.co/hwa6LNzjoF
Our latest research findings on the diagnostic accuracy of multiparametric MRI for detection and localization of prostate cancer. A truly multisciplinary team ! https://t.co/uOutacWbWo #prostate#prostatecancer#urology#treatment
During follow-up, if mpMRI is negative (PI-RADS ≤ 2), and clinical suspicion of #prostatecancer progression is low (low PSA velocity, long PSA doubling time), omit biopsy based on shared decision making with the patient.
#eauguidelines#movember
https://t.co/bfkImm1Hkl
The robotic section of the @EUplatinum just released an article with our own Dr Charles H Rochat as co-author: Best practices in robotic-assisted fistula repair #urology https://t.co/iB557w64Cv
No rest for our focal team during summertime!
Successful Collaboration with Our Besançon friends Pierre Charles Henry and Dr Bally and thé local team led by Martina Martins . Focal Approach of #ProstateCancer has no Borders . Swiss-France Focal!! #prostatecancer#urology
Men with elevated prostate specific antigen #PSA but a low 4Kscore can safely be monitored with repeated blood markers in place of immediate biopsy #ProstateCancer@VickersBiostats@ParStatt
https://t.co/omTMYOTi7X